Day 2: Symposium #1 – Central Park east 

Digital Biomarkers in Cancer Care: Advancing Outcomes Through Integrated Patient Monitoring

9:30 AM

The Overlap of Healing: Wound Care Advancements Driving Better Cancer Outcomes

Thomas Nichols, CEO & Founder, Pretika MedTech

10:00 AM

Digital Biomarkers in Cancer Care: Advancing Outcomes & Opportunities for Research

Erica Olenski, Vice President, FINN Partners

10:35 AM

Networking BREAK

11:00 AM

Bridging the Divide: Tackling Disparities in Cancer Trials and Access

Dr. Larry Norton, Senior VP, Office of the Hospital President, Memorial Sloan Kettering Cancer Center

11:30 AM

Precision Immunotherapy Meets Digital Biomarkers: The Immunogenik Approach to Solid Tumor Resistanc

Jianping Huang, Founder, Immunogenik

Abhilasha Ramasamy, Executive Director and Head, HEOR Evidence Strategy and Synthesis, Novo Nordisk 

12:00 PM

Inside-Out Innovation: Unlocking Personalized Health Intelligence

Natalie Principe, President & Founder, ExtendHealth Consultants, Inc.

12:30 PM

LUNCH

1:30 PM

Backing the Breakthroughs: Where Capital Meets Cancer Innovation

John Hammitt, Global Executive Director, HITLAB

2:00 PM

Accelerating Impact: Collaborations Fueling the Next Generation of Cancer Treatment

Natalie Principe, President & Founder, ExtendHealth Consultants, Inc.

2:30 PM

NETWORKING BREAK

3:00 PM

Workshop

Meg Columbia Walsh, Managing Director, Oberon Securities

3:30 PM

Workshop

Meg Columbia Walsh, Managing Director, Oberon Securities